Form D · Other Health Care

AKANDA CORP.

New Romney, X0 · CIK 0001888014

Offering snapshot reported Nov 29, 2021 · SEC filing

Reported sold: $1.75M
Investors reported: 32
Minimum accepted: $10K
First sale: Nov 12, 2021

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 29, 2021	Initial	$1,750,000	No comparison	32	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $700K (estimated)
Finders' fees: $0
Form D file number: 021-422604

Company is offering a min. of US$5,0000,000 or 2,000,000 shares and up to max. of US$10,000,000 or 4,000,000 shares. Total offering includes shares offered to non-US persons under Regulation S, but total sales and investments reflect US persons only.

Boustead Securities, LLC may be paid an estimated commission of US$700,000 as well as a non-accountable expense allowance of US$100,000 of gross proceeds of the max 4,000,000 common shares of the offering.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Boustead Securities, LLC	141391

Source: Form D, filed Nov 29, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Charles Kie	Director
Louisa Mojela	Director, Executive
Trevor Scott	Executive
Tejinder Virk	Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

1 A, 1 B Learoyd Road
New Romney, X0, TN28 8XU